48,470
edits
Difference between revisions of "Eosinophilic vacuolated tumour"
Jump to navigation
Jump to search
no edit summary
m (Michael moved page High-grade oncocytic renal tumour to Eosinophilic vacuolated tumour: entity renamed) |
|||
| (4 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
| Width = | | Width = | ||
| Caption = Micrograph of a high-grade oncocytic tumour of the kidney. [[H&E stain]]. | | Caption = Micrograph of a high-grade oncocytic tumour of the kidney. [[H&E stain]]. | ||
| Synonyms = | | Synonyms = high-grade oncocytic tumour | ||
| Micro = abundant oncocytic cytoplasm with prominent intracytoplasmic vacuoles, | | Micro = abundant oncocytic cytoplasm with prominent intracytoplasmic vacuoles, | ||
round nuclei, [[prominent nucleoli]] ([[ISUP nucleolar grade]] 3), no perinuclear halos | round nuclei, [[prominent nucleoli]] ([[ISUP nucleolar grade]] 3), no perinuclear halos | ||
| Line 12: | Line 12: | ||
| IHC = PAX8 +ve, CD117 +ve, CD10 +ve, SDHB +ve, TFE3 -ve | | IHC = PAX8 +ve, CD117 +ve, CD10 +ve, SDHB +ve, TFE3 -ve | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = TSC1 or TSC2 mutation | ||
| IF = | | IF = | ||
| Gross = | | Gross = | ||
| Line 32: | Line 32: | ||
| Tx = excision | | Tx = excision | ||
}} | }} | ||
''' | '''Eosinophilic vacuolated tumour''', abbreviated '''EVT''', is a [[kidney tumour]] type currently not recognized by the WHO classification as per the 2016 Blue Book. | ||
It was previously known as '''high-grade oncocytic tumour''', abbreviated '''HOT'''.<ref name=pmid34521993>{{cite journal |authors=Farcaş M, Gatalica Z, Trpkov K, Swensen J, Zhou M, Alaghehbandan R, Williamson SR, Magi-Galluzzi C, Gill AJ, Tretiakova M, Lopez JI, Montiel DP, Sperga M, Comperat E, Brimo F, Yilmaz A, Siadat F, Sangoi A, Gao Y, Ptákova N, Kuthi L, Pivovarcikova K, Rogala J, Agaimy A, Hartmann A, Fraune C, Rychly B, Hurnik P, Durcansky D, Bonert M, Gakis G, Michal M, Hora M, Hes O |title=Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases |journal=Mod Pathol |volume= |issue= |pages= |date=September 2021 |pmid=34521993 |doi=10.1038/s41379-021-00923-6 |url=}}</ref> | |||
==General== | ==General== | ||
| Line 74: | Line 76: | ||
*TFE3 -ve. | *TFE3 -ve. | ||
*[[CD117]] +ve (9 of 14 cases). | *[[CD117]] +ve (9 of 14 cases). | ||
Others: | |||
*CD56 +ve.{{fact}} | |||
**Typically negative in [[renal oncocytoma]]. | |||
==Molecular== | |||
*TSC1 or TSC2 mutation - see [[renal neoplasms with TSC/mTOR pathway mutations]]. | |||
==See also== | ==See also== | ||
| Line 79: | Line 88: | ||
==References== | ==References== | ||
{{Reflist| | {{Reflist|2}} | ||
[[Category:Diagnosis]] | [[Category:Diagnosis]] | ||